CL2018000079A1 - Proceso para la produccion de cannabidiol y delta-9-tetrahidrocannabinol. - Google Patents

Proceso para la produccion de cannabidiol y delta-9-tetrahidrocannabinol.

Info

Publication number
CL2018000079A1
CL2018000079A1 CL2018000079A CL2018000079A CL2018000079A1 CL 2018000079 A1 CL2018000079 A1 CL 2018000079A1 CL 2018000079 A CL2018000079 A CL 2018000079A CL 2018000079 A CL2018000079 A CL 2018000079A CL 2018000079 A1 CL2018000079 A1 CL 2018000079A1
Authority
CL
Chile
Prior art keywords
cannabidiol
compound
derivative
dihalo
tetrahydrocannabinol
Prior art date
Application number
CL2018000079A
Other languages
English (en)
Inventor
Lukas Dialer
Denis Petrovic
Ulrich Weigl
Original Assignee
Noramco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57730761&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2018000079(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Noramco Inc filed Critical Noramco Inc
Publication of CL2018000079A1 publication Critical patent/CL2018000079A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/11Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/11Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
    • C07C37/14Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms by addition reactions, i.e. reactions involving at least one carbon-to-carbon unsaturated bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente descripción se refiere a la preparación de un compuesto de cannabidiol o un derivado del mismo. El compuesto de cannabidiol o un derivado del mismo se puede preparar por medio de una reacción catalizada con ácido de un di-halo-olivetol seleccionado y sustituido adecuadamente o derivado del mismo con un alqueno cíclico seleccionado y sustituido adecuadamente para producir un compuesto de dihalo-cannabidiol o derivado del mismo. El compuesto de dihalo-cannabidiol o derivado del mismo se puede producir con alto rendimiento, alta estereoespecificidad o ambos. Luego, se puede convertir en condiciones reductoras a un compuesto de cannabidiol o derivados del mismo.
CL2018000079A 2015-07-10 2018-01-10 Proceso para la produccion de cannabidiol y delta-9-tetrahidrocannabinol. CL2018000079A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562191097P 2015-07-10 2015-07-10
US15/199,528 US10059683B2 (en) 2015-07-10 2016-06-30 Process for the production of cannabidiol and delta-9-tetrahydrocannabinol

Publications (1)

Publication Number Publication Date
CL2018000079A1 true CL2018000079A1 (es) 2018-08-24

Family

ID=57730761

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2018000079A CL2018000079A1 (es) 2015-07-10 2018-01-10 Proceso para la produccion de cannabidiol y delta-9-tetrahidrocannabinol.
CL2019003154A CL2019003154A1 (es) 2015-07-10 2019-11-04 Proceso de preparación de un compuesto intermediario de fórmula (vi) para la preparación de compuestos de cannabidiol. (divisional solicitud 201800079)

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL2019003154A CL2019003154A1 (es) 2015-07-10 2019-11-04 Proceso de preparación de un compuesto intermediario de fórmula (vi) para la preparación de compuestos de cannabidiol. (divisional solicitud 201800079)

Country Status (21)

Country Link
US (4) US10059683B2 (es)
EP (2) EP3319952B8 (es)
JP (2) JP6810842B2 (es)
CN (1) CN108137526A (es)
AU (2) AU2016294264B2 (es)
BR (1) BR112018000497A2 (es)
CA (1) CA2992043C (es)
CL (2) CL2018000079A1 (es)
CO (1) CO2018001290A2 (es)
CR (1) CR20180094A (es)
DK (1) DK3319952T3 (es)
EC (1) ECSP18010065A (es)
ES (1) ES2784881T3 (es)
HK (1) HK1255390A1 (es)
IL (1) IL256750A (es)
MX (1) MX2018000354A (es)
MY (1) MY182971A (es)
NZ (1) NZ738925A (es)
PH (1) PH12018500093A1 (es)
PT (1) PT3319952T (es)
WO (1) WO2017011210A1 (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2530001B (en) 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
GB2531281A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabidiol in the treatment of intractable epilepsy
US10059683B2 (en) * 2015-07-10 2018-08-28 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US10640482B2 (en) 2017-07-21 2020-05-05 University Of South Florida Synthesis of cannabinoids
WO2019152736A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
CN112313221A (zh) * 2018-02-13 2021-02-02 比托邦制药有限公司 ***素衍生物和缀合物以及其用途
CA3091776C (en) 2018-02-20 2021-12-28 Supera Pharmaceuticals, Inc. Genetically modified cannabis sativa plants and modified cannabinoid compounds for treatment of substance addiction and other disorders
WO2020001770A1 (en) 2018-06-28 2020-01-02 Symrise Ag Synthesis of (+)-cannabinoids and their therapeutic effects
US10736869B2 (en) 2018-07-16 2020-08-11 ECS Health Sciences, Inc. Compositions and methods related to cannabinoids, terpenoids and essential oils
CN108863768A (zh) * 2018-08-03 2018-11-23 上海华堇生物技术有限责任公司 3,5-二甲氧基苯甲酰氯的制备方法
KR20210090609A (ko) * 2018-08-20 2021-07-20 베서, 파마 엘엘씨 공지된 신규 칸나비노이드의 응용
JP2021536490A (ja) * 2018-09-05 2021-12-27 ピュリシス・リミテッド・ライアビリティ・カンパニーPurisys LLC 修飾されたカンナビノイドプロファイルを有するカンナビジオール組成物
EP3864000A4 (en) 2018-10-10 2022-08-10 Treehouse Biosciences, Inc. CANNABIGEROL SYNTHESIS
EP3653596A1 (en) * 2018-11-14 2020-05-20 Indena S.p.A. Continuous flow synthesis of cannabidiol
DE102019104563A1 (de) * 2019-02-22 2020-08-27 Chiracon Gmbh Verfahren zur Herstellung von Cannabidiol
CN109970516A (zh) * 2019-03-20 2019-07-05 栾云鹏 一种工业化制备高纯度高收率的***酚类物质的合成方法
US10981850B2 (en) 2019-04-15 2021-04-20 Trustees Of Boston University One-step flow-mediated synthesis of cannabidiol (CBD) and derivatives
CN111943813B (zh) * 2019-05-17 2023-04-14 上海特化医药科技有限公司 ***二酚类化合物的制备方法
WO2020232545A1 (en) * 2019-05-23 2020-11-26 Kare Chemical Technologies Inc. Catalytic cannabinoid processes and precursors
CA3142008A1 (en) * 2019-05-31 2020-12-03 Purisys Llc Processes for the preparation of halogenated dihydroxybenzene compounds
US20220296482A1 (en) 2019-06-11 2022-09-22 Symrise Ag Synthesis and purification of cannabigerol and its application
WO2020252277A1 (en) * 2019-06-13 2020-12-17 Isomerz, Inc. Making delta 8 thc, delta 10 thc and/or cannabinol from cbd
WO2020252369A1 (en) * 2019-06-14 2020-12-17 Purisys Llc Crystalline cannabigerol
US11542243B1 (en) 2019-09-26 2023-01-03 FusionFarms, LLC Method of converting delta9-THC to delta10-THC and the purification of the delta10-THC by crystallization
US11419800B2 (en) 2019-12-06 2022-08-23 JLABS Beauty LLC Topical compositions containing rose oil and cannabidiol and methods of making and using the same
EP4081206A4 (en) * 2019-12-27 2023-11-29 BayMedica, Inc. PREPARATION OF CANNABICHROMENE AND RELATED CANNABINOIDS
US20230227482A1 (en) * 2020-01-08 2023-07-20 Chengdu Baiyu Pharmaceutical Co., Ltd. Tetrahydrocannabinol derivatives, preparation method thereof and use thereof
CN113087741B (zh) * 2020-01-08 2023-04-28 成都百裕制药股份有限公司 ***二酚衍生物及其制备方法和在医药上的应用
EP4089084A4 (en) * 2020-01-08 2024-03-13 Chengdu Baiyu Pharmaceutical Co., Ltd. CANNABIDIOL DERIVATIVE AND ITS PREPARATION METHOD AND ITS MEDICAL USE
CA3168491A1 (en) * 2020-01-24 2021-07-29 Perkinelmer Health Sciences, Inc. Cannabinoid derivatives
US10981849B1 (en) * 2020-02-20 2021-04-20 Sci Pharmtech Inc. Method for preparing cannabinoids
GB202002754D0 (en) 2020-02-27 2020-04-15 Gw Res Ltd Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
WO2021181420A1 (en) 2020-03-12 2021-09-16 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) Process for the synthesis of cannabidiol and intermediates thereof
EP4126800A1 (en) 2020-03-31 2023-02-08 Phytotherapeutix Ltd Terpenophenolic compounds and their use
CA3179442A1 (en) 2020-05-22 2021-11-25 Brian Warrington Compositions for treating acne and dermatological conditions
CN112094257B (zh) * 2020-08-19 2023-08-22 公安部禁毒情报技术中心 一种△-9四氢***酚的制备方法
CN112811980B (zh) * 2020-12-01 2022-03-25 山东金城金奥医药科技有限公司 一种绿色光氧化连续制备***二酚中间体的方法
MX2023007173A (es) 2020-12-17 2023-09-08 Nalu Bio Inc Sintesis de cannabidiol y analogos del mismo, y compuestos relacionados, formulaciones y procedimientos de uso.
US11242328B1 (en) * 2021-02-25 2022-02-08 Acid Neutral Alkaline Laboratory Heterogeneous catalyst and method for preparation of aromatic tricyclic pyrans
US11242330B1 (en) * 2021-02-25 2022-02-08 Acid Neutral Alkaline Laboratory Organic catalyst and method for preparation of aromatic tricyclic pyrans
US20220306598A1 (en) * 2021-03-25 2022-09-29 Precision Extraction Corporation Method for highly selective conversion of cbd to delta-8 thc
US11352337B1 (en) * 2021-06-02 2022-06-07 Acid Neutral Alkaline Laboratory Zeolite catalyst and method for preparation of aromatic tricyclic pyrans
CN113603568A (zh) * 2021-07-19 2021-11-05 厦门朝阳生物工程有限公司 一种***二酚的制备方法
WO2023086447A2 (en) * 2021-11-12 2023-05-19 Pureform Global, Inc. A method for the synthesis of cannabinol
WO2024028516A1 (en) 2022-08-05 2024-02-08 Salud & Semillas, S.L. CANNABINOID SYNTHESIS STARTING OUT FROM OLIVETOL AND TERPENE IN DICHLOROMETHANE WITH FeCl3 * 6H2O AS CATALYST

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH473075A (de) 1966-11-04 1969-05-31 Theodor Dr Petrzilka Verfahren zur Herstellung von in 2-Stellung substituierten Resorcinderivaten
DE4100441A1 (de) 1991-01-09 1992-07-16 Mack Chem Pharm Verfahren zur herstellung von 6,12-dihydro-6-hydroxy-cannabidiol und dessen verwendung zur herstellung von trans-delta-9-tetrahydrocannabinol
AU6088200A (en) 1999-07-12 2001-01-30 Virginia Commonwealth University Novel vasodilator cannabinoid analogs
US8034843B2 (en) * 2002-02-01 2011-10-11 Gw Pharma Limited Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions
GB2393182B (en) * 2002-09-23 2007-03-14 Gw Pharma Ltd Method of preparing cannabidiol from plant material
CA2526103A1 (en) * 2003-05-20 2004-12-29 Bob M. Ii Moore Cannabinoid derivatives, methods of making, and use thereof
US7323576B2 (en) 2004-10-01 2008-01-29 Alphora Research Inc. Synthetic route to dronabinol
TWI369203B (en) * 2004-11-22 2012-08-01 Euro Celtique Sa Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
DE102005028937B4 (de) * 2005-06-22 2009-07-23 Bionorica Ag Verfahren zur Herstellung von Dronabinol
EP1928853A4 (en) 2005-09-29 2011-02-16 Amr Technology Inc PROCESS FOR THE PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL
CA2751741C (en) * 2008-02-06 2018-07-10 Mallinckrodt Inc. Process for the preparation of (-) -delta 9-tetrahydrocannabinol
DE102009019322A1 (de) * 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
PT3274321T (pt) * 2015-03-23 2019-10-28 Echo Pharmaceuticals Bv Isolado de canabidiol em câmara industrial e sua utilização em preparações farmacêuticas e/ou cosméticas
DK3302437T3 (da) * 2015-05-28 2023-01-09 Radius Pharmaceuticals Inc Stabile cannabinoidformuleringer
US10059683B2 (en) * 2015-07-10 2018-08-28 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol

Also Published As

Publication number Publication date
US20170008869A1 (en) 2017-01-12
CA2992043A1 (en) 2017-01-19
US20210061781A1 (en) 2021-03-04
JP2020037596A (ja) 2020-03-12
PT3319952T (pt) 2020-04-22
US10059683B2 (en) 2018-08-28
EP3319952B8 (en) 2020-03-11
US20180319763A1 (en) 2018-11-08
JP6810842B2 (ja) 2021-01-13
DK3319952T3 (da) 2020-03-23
AU2019229416A1 (en) 2019-10-03
MY182971A (en) 2021-02-05
AU2016294264B2 (en) 2019-06-13
EP3722276A1 (en) 2020-10-14
IL256750A (en) 2018-03-29
US10844035B2 (en) 2020-11-24
MX2018000354A (es) 2018-08-15
EP3319952A1 (en) 2018-05-16
CN108137526A (zh) 2018-06-08
EP3319952B1 (en) 2020-02-05
CO2018001290A2 (es) 2018-04-19
BR112018000497A2 (pt) 2018-09-11
PH12018500093A1 (en) 2018-07-09
CA2992043C (en) 2020-04-14
ES2784881T3 (es) 2020-10-01
US20170008868A1 (en) 2017-01-12
ECSP18010065A (es) 2018-05-31
AU2016294264A1 (en) 2018-02-01
CR20180094A (es) 2018-06-14
HK1255390A1 (zh) 2019-08-16
WO2017011210A1 (en) 2017-01-19
NZ738925A (en) 2019-05-31
JP2018522944A (ja) 2018-08-16
CL2019003154A1 (es) 2020-03-06

Similar Documents

Publication Publication Date Title
CL2018000079A1 (es) Proceso para la produccion de cannabidiol y delta-9-tetrahidrocannabinol.
DOP2021000179A (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
BR112018071060A2 (pt) produção de monômeros de lignina durante a despolimerização de uma composição contendo lignocelulose
BR112012026256B8 (pt) métodos para produção de biocombustível
RU2012110715A (ru) Способ получения микрокапсул
CO2020001927A2 (es) Método de producción de composiciones farmacéuticas que comprende el virus chikungunya inmunogénico chikv-delta5nsp3
BR112017014710A2 (pt) produção de composições de ramnolipídeo
BR112014026053A2 (pt) método de preparo de para-xileno a partir de biomassa
BR112013018703A2 (pt) processo para a produção de óxido de etileno
BR112017028128A2 (pt) ?processo para a preparação de uma poliamida?
CU24579B1 (es) Proceso de preparación de una vacuna tetravalente atenuada contra el virus del dengue
BR112015029399A2 (pt) produção em etapa única de uma composição de polipropileno
BR112016013316A8 (pt) método para a produção de furfural e uso de ácido metanossulfônico
MX2017001459A (es) Sintesis de fosforamidatos.
BR112017001177A2 (pt) processo para a purificação de poliovírus a partir de culturas celulares
BR112016025024A2 (pt) ?processo para preparar compostos ceto, e, uso de farnesil acetona?
BR112016011899A2 (pt) Processo para preparação de 5-fluoro-1h-pirazóis
BR112017018993A2 (pt) Processo para preparar 3-cloro-2- vinilfenilassulfonatos
CO6470817A2 (es) Cristales de solvato novedosos
BR112016016397A2 (pt) método para preparar 1-alquil-3-difluorometil-5-fluoro-1h-pirazol-4-carbaldeídos e 1-alquil-3-difluorometil-5-fluoro-1h-pirazol-4-carboxilatos.
BR112016022437A2 (pt) Processo para preparação de (2s,5r)-6-(benziloxi)-7-oxo-1,6- diazabiciclo[3,2,1]octano-2-carboxilato de sódio
BR112015028751A2 (pt) processo para a preparação de derivados de 3,5-bis (fluoralquil)pirazol a partir de alfa,alfa-dihaloaminas
RU2011112721A (ru) Способ получения гидропероксида n-цимола
BR112017008663A2 (pt) método para a produção de álcool
BR112016029698A2 (pt) reação de prins em substratos impedidos